A Tale Of A Diabetes Pizza Study

A Tale of a Diabetes Pizza Study

A Tale of a Diabetes Pizza Study

Dario doesnt just log and track glucose levels, it charts carb intake, insulin doses, exercise, moods, and more and gives you insights to help understand what may be effecting your blood glucose. The user-centric design of the Dario app allows logbooks, timelines, and charts to be easily shared with loved ones and healthcare providers.
Download the Dario App today and scroll down for more information on how to get started.
For questions regarding the set up and use of your Dario Blood Glucose Monitoring System, orders, or other technical support issues, please contact our Customer Service Center at 1-800-895-5921, Monday Friday, 9AM 5PM Eastern.
For general inquiries about the Dario Blood Glucose Monitoring System, please fill out the form below and a representative will reach out to you.
This form is not for technical support or medical advice. For technical support issues, please call our toll free number 1-800-895-5921 for assistance. If there is an urgent medical issue, please contact your physician.
When pizza meets diabetes in a medical research.
You may have a certain image that comes to mind when you think of a clinical trial. But did you know that a study can involve eating pizza?
There are certain foods that I have to eat with aspray and pray mentality where I can only hope for the best. All too often though, the best is rarely realized. When I was approached by the Joslin Institute for Transformational Technology Program, which is new group headed by Dr. Howard Wolpert in Boston, and they asked me to be a subject in a pizza study, I signed up right awa Continue reading

Rate this article
Total 1 ratings
Why Are We Waiting To Treat Diabetes Until A1c Reaches 6.5%?

Why Are We Waiting To Treat Diabetes Until A1c Reaches 6.5%?

Home / Conditions / Prediabetes / Why Are We Waiting To Treat Diabetes Until A1c Reaches 6.5%?
Why Are We Waiting To Treat Diabetes Until A1c Reaches 6.5%?
Getting type 2 diabetes at an early age increases risk for all diabetes complications, including death.
Going back years, the diagnosis of diabetes was a fasting plasma glucose (FPG) of 180 mg/dl. Today, its an FPG of 126 mg/dl or greater, or an A1C of 6.5% or greater. But should the diagnostic standard move even further, to 100 mg/dl, a lower A1C, and treatment for diabetes start much earlier?
To examine the association between early onset of type 2 diabetes mellitus (DM) and clinical behavioral risk factors for later complications of diabetes, 5,115 people with type 2 were enrolled in a cross-sectional study. Risk factors at time of diagnosis among those diagnosed at 45 years (early onset) with diagnosis age 46 to 55, 56 to 65 (average onset = reference), 66 to 75, and >75 years (late onset) were recorded.
According to the analysis, being diagnosed with type 2 diabetes at a young age comes with more serious complications and higher rates of death than being diagnosed later in life.
We know that it takes many years to develop complications in diabetes and having type 2 at a younger age equates to a higher lifetime risk of complications given the projected length of exposure to high glucose and other risk factors. This includes higher death rates, which rose to six times higher when subjects were in early middle age.
Those diagnosed between ages 15 and 30 had more severe nerve damage and signs of early kidney di Continue reading

Unprocessed Red and Processed Meats and Risk of Coronary Artery Disease and Type 2 Diabetes  An Updated Review of the Evidence

Unprocessed Red and Processed Meats and Risk of Coronary Artery Disease and Type 2 Diabetes An Updated Review of the Evidence

Unprocessed Red and Processed Meats and Risk of Coronary Artery Disease and Type 2 Diabetes An Updated Review of the Evidence
We are experimenting with display styles that make it easier to read articles in PMC. The ePub format uses eBook readers, which have several "ease of reading" features already built in.
The ePub format is best viewed in the iBooks reader. You may notice problems with the display of certain parts of an article in other eReaders.
Generating an ePub file may take a long time, please be patient.
Unprocessed Red and Processed Meats and Risk of Coronary Artery Disease and Type 2 Diabetes An Updated Review of the Evidence
Renata Micha, Georgios Michas, and Dariush Mozaffarian
Growing evidence suggests that effects of red meat consumption on coronary heart disease (CHD) and type 2 diabetes could vary depending on processing. We reviewed the evidence for effects of unprocessed (fresh/frozen) red and processed (using sodium/other preservatives) meat consumption on CHD and diabetes. In meta-analyses of prospective cohorts, higher risk of CHD is seen with processed meat consumption (RR per 50 g: 1.42, 95 %CI = 1.071.89), but a smaller increase or no risk is seen with unprocessed meat consumption. Differences in sodium content (~400 % higher in processed meat) appear to account for about two-thirds of this risk difference. In similar analyses, both unprocessed red and processed meat consumption are associated with incident diabetes, with higher risk per g of processed (RR per 50 g: 1.51, 95 %CI = 1.251.83) v Continue reading

Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations

Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations

Type 2 diabetes mellitus (DM) and obesity are chronic diseases that often coexist. Combined, they account for tremendous morbidity and mortality. Approximately 85% of all patients with type 2 DM have a body mass index (BMI) categorizing them as overweight (BMI 25.0–29.9 kg/m) or obese (BMI > 30.0 kg/m) (Figure 1). Obesity is strongly associated with diabetes and is a major cause of insulin resistance that leads to the cascade of hyperglycemia, glucotoxicity, and beta-cell failure, which ultimately leads to the development of microvascular (neuropathy, nephropathy, retinopathy) and macrovascular (myocardial infarction, stroke) complications. Treatment guidelines emphasize that both diabetes and obesity should be treated to optimize long-term outcomes. Metabolic surgery is the only diabetes treatment proven to result in long-term remission in 23% to 60% of patients depending upon preoperative duration of diabetes and disease severity. This review presents the evidence supporting use of metabolic surgery as a primary treatment for type 2 DM, potential mechanisms for its effects, associated complications, and recommendations for its use in expanded patient populations.
First-line therapy with lifestyle management and second-line therapy with medications, including oral agents and insulin, are the mainstays of type 2 DM therapy. Although these approaches have reduced hyperglycemia and cardiovascular mortality, many patients have poor glycemic control and develop severe diabetes-related complications. A study using data from the National Health and Nutrition Examination Survey Continue reading

Diabetes Tech on the Horizon Part 3 - What to Expect for CGM in 2018

Diabetes Tech on the Horizon Part 3 - What to Expect for CGM in 2018

Diabetes Tech on the Horizon Part 3 - What to Expect for CGM in 2018
Learn more about new and upcoming glucose monitoring products whats available now and what could be coming soon
Diabetes technology moves fast, so to help you keep track, weve rounded up some of the latest offerings and things coming soon related to CGM. (See here for updates about diabetes apps and software, and here for insulin delivery updates.) Below, youll find products that have recently become available or are expected to launch in the next year or so based on the most recent timing updates weve heard. This article is not fully comprehensive and timelines often change but this list covers many of the most notable CGM products. A more detailed description of each product follows the table of contents below.
Abbott FreeStyle Libre (real time) Just launched in US pharmacies (CVS, Walgreens, Walmart, Kroger, Rite Aid) with a prescription
Dexcoms G6 sensor with push-button applicator and 30% thinner transmitter currently under FDA review, US launch expected in 2018 (possibly with no fingerstick calibration)
Launched in US pharmacies in late November 2017
Whats New? Following FDA approval in September , Abbotts long-awaited, no-fingersticks-needed FreeStyle Libre real-time CGM has launched in US pharmacies: Walgreens, CVS, Walmart, Kroger, and Rite Aid. Currently, there is no US reimbursement for FreeStyle Libre, though the cash pay price is less expensive than other CGM systems. We called our local Walgreens and CVS and learned that each 10-day sensor costs approximately $43-$53 ($129-$159 Continue reading

No more pages to load

Popular Articles

  • Diabetes and obesity linked to number of nearby fast-food outlets, study finds

    Diabetes and obesity rates in inner cities can be linked to the number of fast-food outlets near people’s homes, a study has found. Scientists based their conclusion on a study of 10,000 people in the UK. They found there were twice as many fast-food outlets within 500 metres of homes in non-white and socially deprived neighbourhoods. The lead researcher, Prof Kamlesh Khunti from the University ...

  • Reversing Type 2 Diabetes Is Possible Through Weight Loss, Study Finds

    December 7, 2017 Type 2 diabetes has long been viewed as an incurable, chronic condition that often requires lifelong management through medication, such as Glucophage (metformin) and insulin. But a study published in December 2017 in the journal The Lancet suggested following a radical diet that restricts calorie consumption to under 1,000 per day has the potential to reverse the disease in some ...

  • Type 2 diabetes can be REVERSED by strict weight loss programme without medication, study finds

    Type 2 diabetes can be completely reversed by a weight loss programme without any medication, a study has found. The landmark trial of UK adults published in the Lancet showed that 46% of patients on the strict calorie counting programme who lost an average of 10kg were ‘cured’ a year later. That compared to only 4% of a second group which followed the current best practice treatment of GPs’ ...

  • Rigorous diet can put Type 2 diabetes into remission, study finds

    Some people with Type 2 diabetes were able to put the disease in remission without medication by following a rigorous diet plan, according to a study published today in the Lancet medical journal. "Our findings suggest that even if you have had Type 2 diabetes for six years, putting the disease into remission is feasible," Michael Lean, a professor from the University of Glasgow in Scotland who co ...

  • Regular drinking can reduce risk of developing diabetes, study suggests

    Drinking alcohol three to four times per week could significantly reduce a person's chances of developing diabetes, according to a new study. Wine is tipped to be the most beneficial, followed by beer, but researchers warn that clear spirits, such as gin and vodka, could substantially increase a woman's chances of succumbing to the condition. Experts argue, however, that the health impacts of alco ...

  • Study Finds Half of U.S. Adults Have Diabetes or Prediabetes

    Recently, researchers set out to quantify just how prevalent the disease and its precursor are among American adults. In a large population-based study(jama.jamanetwork.com) published Sept. 8 in JAMA: the Journal of the American Medical Association, authors examined the prevalence of diabetes and prediabetes and related disease trends in U.S. adults from 1988-2012. One of the most startling findin ...

  • Looking to cure Type 1 diabetes, investors front $114M to launch a pioneering human study at Semma

    Three years ago, Harvard’s Doug Melton published a landmark study outlining how he had successfully used stem cells to create insulin-producing pancreatic beta cells that were inserted in bulk into mice and successfully protected from an immune response — a breakthrough in regenerative medicine that bore real promise to provide a curative approach for Type 1 diabetes that could conceivably end ...

  • Diabetes is even deadlier than we thought, study suggests

    Nearly four times as many Americans may die of diabetes as indicated on death certificates, a rate that would bump the disease up from the seventh-leading cause of death to No. 3, according to estimates in a recent study. Researchers and advocates say that more-precise figures are important as they strengthen the argument that more should be done to prevent and treat diabetes, which affects the wa ...

  • In a New Study, Researchers Claim They’ve Found a Way to Reverse Type 2 Diabetes

    Reversing Type 2 Diabetes Researchers from Newcastle and Glasgow Universities believe they have found a way to effectively reverse type 2 diabetes, without requiring a new kind of drug or invasive surgery. Type 2 diabetes is a chronic condition that affects how a person’s body metabolizes sugar, either because they’ve developed resistance to the hormone insulin, or their pancreas fails to prod ...

Related Articles